Zydus Life shares in focus after Ahmedabad injectables unit clears USFDA inspection

The inspection was conducted from February 16 to 19, 2026 and closed with nil observations, the company said in a release to the exchanges.

Leave a Reply

Your email address will not be published. Required fields are marked *